Dermal Papilla Tissue Auto-Aggregation for Alopecia Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating alopecia, such as artificial hair implantation and human hair transplantation, are ineffective and limited, and existing in vitro hair follicle cell culture techniques result in loss of hair follicle inductive potency after a few passages, making it difficult to produce sufficient dermal papilla tissues for hair regeneration.
Innovation Solution
A method involving the isolation and culture of dermal papilla and lower dermal sheath cells in a primary medium followed by auto-aggregation in a secondary medium with high concentrations of amino acids, vitamins, and a growth factor, without the use of a matrix or substrate, to produce dermal papilla tissues with sustained hair follicle inductive potency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If dermal papilla cells are cultured in conventional media, then cell proliferation occurs, but hair follicle inductive potency is lost after 3-4 passages
Solution Approach 1:
The patent applies parameter changes by modifying the culture medium composition to high concentrations of amino acids (2,000-3,000 mg/l), vitamins (40-60 mg/l), and growth factors (0.1-10,000 ng/ml). This specific parameter optimization allows dermal papilla cells to maintain their hair follicle inductive potency for extended periods (beyond 3-4 passages) while continuing to proliferate, directly resolving the contradiction between productivity and reliability
Solution Approach 2:
The patent employs preliminary action by pre-culturing dermal papilla and lower dermal sheath cells together in a primary culture medium before transplantation. This preliminary co-culture establishes and maintains the inductive potency of dermal papilla cells, ensuring they retain their ability to induce hair follicle formation when transplanted, thus preserving reliability while achieving sufficient cell numbers
2Reliability
If human hair transplantation is performed, then permanent hair growth is achieved, but the number of transplanted hairs is limited and the procedure is tedious and expensive
Solution Approach 1:
The patent extracts and isolates the essential inductive component (dermal papilla cells) from complete hair follicles. By culturing and expanding these isolated cells in specialized media, the patent enables production of sufficient cell numbers for transplantation without being limited by donor site constraints, thereby increasing productivity while maintaining the reliability of permanent hair growth through proven inductive potency
Solution Approach 2:
The patent creates copies of dermal papilla cells through in vitro proliferation. By culturing a small initial sample of dermal papilla cells in optimized media, large numbers of identical cells with maintained inductive potency can be produced, effectively copying the essential hair-inducing component and overcoming the limitation on the number of transplanted units
3Reliability
If dermal papilla cells are cultured in waste medium of epithelial cells, then hair follicle inductive ability is retained, but the method is not scalable for mass production
Solution Approach 1:
The patent transforms the culture condition from using waste medium to a precisely formulated medium with high concentrations of amino acids (2,000-3,000 mg/l), vitamins (40-60 mg/l), and growth factors (0.1-10,000 ng/ml). This parameter optimization maintains the hair follicle inductive ability while enabling scalable, controlled, and reproducible mass production of dermal papilla cells
Data Source
AI summary
The inventive method for the preparation of a dermal papilla tissue in accordance with the present invention makes it possible to form a quantity of the dermal papilla tissues having hair follicle inductive ability, and accordingly, it can be effectively used for the treatment of alopecia through cell transplantation.